Asia Pacific Peptide Synthesis Market (2024-2029)
The Asia Pacific Peptide Synthesis Market was valued at $206.6 Million in 2024 and projected to reach to $336.1 Million by 2029, representing a compound annual growth rate of 10.2%. The Asia Pacific peptide synthesis market is positioned for sustained growth through 2029, with the region's valuation expanding from $206.6 million to $336.1 million.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Asia Pacific Peptide Synthesis Market Trends and Insights
- Asia Pacific's growth trajectory reflects increasing pharmaceutical R&D investments, rising demand for biologics, and expanding contract manufacturing capabilities across the region.
- The 10.2% compound annual growth rate in Asia Pacific significantly outpaces global trends, driven by cost-competitive manufacturing, regulatory improvements, and growing adoption of peptide-based therapeutics in countries including China, India, and Japan. Asia Pacific's peptide synthesis market benefits from a robust ecosystem of contract research organizations (CROs) and contract manufacturing organizations (CMOs) that serve global pharmaceutical companies.
- The region's competitive labor costs, advanced infrastructure, and increasing technical expertise position Asia Pacific as a preferred destination for peptide production and development.
- Between 2024 and 2029, Asia Pacific is expected to capture an expanding share of global peptide synthesis activity, supported by rising healthcare expenditures and accelerating clinical development programs targeting Asian patient populations..
Key Market Statistics
- CAGR (2024-2029) 10.2% CAGR
- Market Size, 2024 ~USD 206.6 Million
- Forecast, 2029 ~USD 336.1 Million
- Geography Asia Pacific
Asia Pacific Peptide Synthesis Market Overview
Rapid Market Expansion :
Asia Pacific peptide synthesis market is growing at 10.2% CAGR, outpacing the global rate of 8.7%, driven by increasing pharmaceutical R&D investments and biologics demand across the region.
Contract Manufacturing Growth :
Expanding contract manufacturing capabilities in Asia Pacific are attracting global pharmaceutical companies seeking cost-effective peptide synthesis solutions and specialized production expertise.
China's Market Leadership :
China dominates Asia Pacific with $89.1 million market size, leveraging its robust chemical manufacturing infrastructure and growing biotech sector investments.
Emerging Biotech Hubs :
Japan ($61.8M) and India ($31.1M) are emerging as key innovation centers, with increasing government support for biotechnology development and peptide-based drug discovery initiatives.
Asia Pacific Peptide Synthesis Market Dynamics
- This trajectory reflects structural advantages including lower manufacturing costs, expanding research infrastructure, and increasing adoption of peptide therapeutics in treating chronic diseases.
- Government initiatives supporting biotech development and rising pharmaceutical R&D spending across major economies are accelerating market penetration. Key growth drivers include rising demand for personalized medicine, contract manufacturing outsourcing from Western markets, and strengthening regulatory frameworks.
- The region's competitive advantage in cost-effective production, combined with improving quality standards and technological capabilities, positions Asia Pacific as a critical hub for global peptide synthesis.
- Strategic investments in automation and advanced synthesis technologies will further enhance market competitiveness through 2029..
Market Ecosystem
PEPTIDE SYNTHESIS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Has worked with GenScript Biotech Corporation (China) to generate thousands of peptides used to study T-cell receptor recognition and identify novel targets for solid-tumor therapeutics. | Enabled large-scale generation of diverse peptide libraries required for target discovery, supporting identification of tumor-specific targets and development of potentially safer and more effective T-cell receptor therapies. |
 |
Uses Biotage AB (Sweden) peptide synthesis and downstream processing technologies, including Syro automated peptide synthesizers, Initiator+ microwave systems, Isolera purification systems, and V-10 evaporation systems, within its peptide drug-discovery workflows. | Parallel synthesis increased peptide throughput, while heated synthesis shortened coupling times for certain reactions from around one hour to about 10 minutes. The integrated workflow also supports difficult sequences, faster purification, and expansion of peptide discovery programs. |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
Related Ecosystem
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- Asia Pacific peptide synthesis market valued at $206.6M in 2024, expanding to $336.1M by 2029 at 10.2% CAGR
- Asia Pacific's growth rate of 10.2% outpaces the global CAGR of 8.7%, reflecting regional competitive advantages
- Asia Pacific's cost-effective manufacturing and expanding CRO/CMO infrastructure drive peptide synthesis adoption
- Rising pharmaceutical R&D investments and biologics demand position Asia Pacific as a key global peptide production hub
Peptide Synthesis Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | CANCER (Indication) |
| Forecast Period | 2024–2029 |
| Growth Rate | CAGR of 8.7% from 2024 to 2029 |
| Largest Segment | CHEMICAL METHODS (Technique) |
| Market Size Base Year (Billions) | ~USD 0.93 (2024) |
| Revenue Forecast (Billions) | ~USD 1.41 (2029) |
| Segments Covered | Offering, Type, Technique, Application, Indication |
Asia Pacific Peptide Synthesis Market Report Segmentation
5 segment dimensions are covered across the global market.
By Offering
- Products
- Services
By Type
- Amino Acids
- Automated Peptide Synthesizers
- Chromatography Systems
- Cleavage Reagents
- Consumables
- Coupling Reagents
- Deprotection Reagents
- Dyes & Fluorescent Labeling Reagents
- Enzymatic Synthesis
- Instruments
- Liquid-Phase Peptide Synthesis
- Lyophilizers
- Manual Peptide Synthesizers
- Other Chemical Methods
- Other Consumables
- Other Instruments
- Other Reagents
- Peptide Synthesizers
- Reagents
- Recombinant Dna Technology
- Resins
- Solid-Phase Peptide Synthesis
By Technique
- Biological Methods
- Chemical Methods
By Application
- Diagnostic Applications
- Discovery & Development Applications
- Therapeutic Applications
By Indication
- Autoimmune Diseases
- Cancer
- Diabetes
- Obesity
- Other Diseases
Target Audience
- Pharmaceutical Companies : Require Asia Pacific market intelligence for outsourcing decisions, contract manufacturer selection, and regional R&D investment strategies to optimize peptide drug development costs.
- Contract Manufacturing Organizations (CMOs) : Need competitive positioning data, market sizing, and growth forecasts to identify expansion opportunities and benchmark capabilities against regional and global competitors.
- Biotech & Life Sciences Investors : Seek regional market trends, country-specific valuations, and growth drivers to evaluate investment opportunities in Asia Pacific peptide synthesis and related biotechnology ventures.
- Government & Regulatory Bodies : Utilize market data for biotech policy development, R&D funding allocation, and strategic planning to strengthen Asia Pacific's position in global peptide synthesis markets.
- Equipment & Technology Suppliers : Need market forecasts and regional demand insights to guide product development, sales strategies, and market penetration initiatives across Asia Pacific's growing peptide synthesis sector.
Key Companies in the Asia Pacific Peptide Synthesis Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| FLUOR CORPORATION | United States | Public Company | Energy Solutions (oil, gas, chemicals, LNG, power, energy transition),Urban Solutions (advanced technologies, life sciences, mining, infrastructure, staffing, maintenance),Mission Solutions (government nuclear, remediation, security, logistics, O&M), |
| MERCK KGAA | Germany | Public Company | Life Science (tools, consumables, CDMO, bioprocessing),Healthcare (prescription drugs and biopharmaceuticals),Electronics (semiconductor and display materials, gases, equipment), |
| AGILENT TECHNOLOGIES, INC. | United States | Public Company | Life Sciences and Diagnostics Markets,Agilent CrossLab,Applied Markets, |
| GENSCRIPT | Hong Kong | Public Company | Life Science Services and Products,Biologics Development Services,Industrial Synthetic Biology Products, |
| BACHEM | Switzerland | Public Company | Peptide NCE APIs (clinical and commercial),Generic peptide APIs,Oligonucleotide NCE APIs, |
| SYNGENE INTERNATIONAL LIMITED | India | Public Company | Discovery chemistry,Discovery biology and DMPK,Development services (chemical, formulation, analytical, clinical), |
| BIOTAGE | Sweden | Private Company | Flash chromatography systems and consumables,Sample preparation and SPE workflows,Biomolecule purification (antibody, plasmid, AAV, tagged proteins), |
| CEM CORPORATION | Mexico | Public Company | Gray ordinary Portland cement,White and blended cement, masonry products,Ready-mix concrete (standard and specialty), |
FLUOR CORPORATION
Fluor Corporation is a publicly traded engineering and construction company founded in 1912 and headquartered in the United States. With approximately 23,000 employees, the company provides design, engineering, procurement, and construction services across multiple industries.
MERCK KGAA
Merck KGaA is a German publicly traded pharmaceutical, chemical, and life sciences company with roots dating back to 1668. The company employs approximately 59,000 people and operates globally across healthcare, life sciences, and performance materials sectors.
AGILENT TECHNOLOGIES, INC.
Agilent Technologies, Inc. is a publicly traded American company founded in 1999 that specializes in life sciences, diagnostics, and applied chemical markets. With approximately 18,000 employees, Agilent provides instruments, software, services, and consumables for laboratory and clinical settings.
GENSCRIPT
GenScript is a Hong Kong-based publicly traded biotechnology company founded in 2002 with approximately 6,165 employees. The company provides gene synthesis, protein production, and drug discovery services to support research and development globally.
BACHEM
Bachem is a Swiss publicly traded company founded in 1971 with approximately 2,725 employees specializing in the production of biochemical compounds. The company serves the pharmaceutical, biotechnology, and diagnostics industries with custom synthesis and manufacturing services.
SYNGENE INTERNATIONAL LIMITED
Syngene International Limited is an Indian publicly traded company founded in 1993 with approximately 6,692 employees providing integrated drug discovery and development services. The company offers preclinical, clinical, and manufacturing services to pharmaceutical and biotechnology clients worldwide.
BIOTAGE
Biotage is a Swedish private company founded in 1969 with approximately 622 employees specializing in laboratory chemistry and sample preparation solutions. The company develops and manufactures instruments and consumables for pharmaceutical, chemical, and environmental analysis.
CEM CORPORATION
CEM Corporation is a publicly traded company founded in 1906 and headquartered in Mexico with approximately 38,495 employees. The company operates across multiple industrial and commercial sectors providing manufacturing and related services.
Countries within Asia Pacific - compare and drill down
| Country | 2025 size (native) |
|---|---|
| China | USD 89.1 Million |
| Japan | USD 61.8 Million |
| India | USD 31.1 Million |
| South Korea | USD 24.7 Million |
| Australia | USD 10.9 Million |
| Rest Of Asia Pacific | USD 37.6 Million |
Country market size visualization
Reasons to Buy this Report
- Regional Market Sizing & Forecasts : Detailed market valuations for Asia Pacific and individual country breakdowns (China, Japan, India, South Korea, Australia) with 5-year projections enabling precise regional investment planning.
- Competitive Landscape Analysis : Comprehensive insights into Asia Pacific's contract manufacturing ecosystem, emerging biotech hubs, and competitive positioning of regional players versus global manufacturers.
- Growth Driver Identification : In-depth analysis of region-specific growth catalysts including government biotech initiatives, R&D spending trends, and regulatory developments shaping market dynamics.
- Country-Level Opportunity Assessment : Granular market data for China, Japan, India, and other key markets, identifying high-potential segments and emerging opportunities for market entry and expansion.
- Strategic Decision Support : Actionable intelligence for manufacturing location selection, partnership development, and resource allocation across Asia Pacific's diverse peptide synthesis landscape.
Frequently asked questions
What is the current size of the Asia Pacific peptide synthesis market?
The Asia Pacific peptide synthesis market was valued at $206.6 million in 2024 and is projected to grow to $336.1 million by 2029.
What is the growth rate for peptide synthesis in Asia Pacific?
Asia Pacific's peptide synthesis market is growing at a compound annual growth rate (CAGR) of 10.2% from 2024 to 2029.
Why is Asia Pacific's peptide synthesis market growing faster than the global average?
Asia Pacific benefits from cost-competitive manufacturing, expanding CRO/CMO infrastructure, regulatory improvements, and increasing pharmaceutical R&D investments that drive faster growth than the global 8.7% CAGR.
Which countries in Asia Pacific are leading peptide synthesis market growth?
China, India, and Japan are primary drivers of Asia Pacific's peptide synthesis market expansion due to advanced infrastructure, technical expertise, and significant pharmaceutical manufacturing capabilities.
What factors are driving demand for peptide synthesis services in Asia Pacific?
Key drivers include rising healthcare expenditures, increasing adoption of peptide-based therapeutics, growing clinical development programs, and Asia Pacific's position as a preferred outsourcing destination for global pharmaceutical companies.
RESEARCH METHODOLOGY
This research study relied extensively on secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global peptide synthesis market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives at major market players, and industry consultants, to gather and validate critical qualitative and quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with primary research inputs to arrive at the final market size.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the peptide synthesis market. The secondary sources used for this study include US Food and Drug Administration (FDA), European Medicines Agency (EMA), National Institutes of Health (NIH), European Directorate for the Quality of Medicines & HealthCare (EDQM), Japan Pharmaceuticals and Medical Devices Agency (PMDA), World Health Organization (WHO), US Pharmacopeia (USP), ClinicalTrials.gov, Journal of Peptide Science, International Journal of Peptide Research and Therapeutics, Peptide Science, American Peptide Society (APS), European Peptide Society (EPS), Chemical & Engineering News (C&EN), Genetic Engineering & Biotechnology News (GEN), and BioPharm International; corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; and trade, business, professional associations, among others. These sources were also used to obtain key information on major players, market classification and segmentation aligned with industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among others, to obtain and verify critical qualitative and quantitative information and to assess the market's future prospects. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the peptide synthesis market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following.
Peptide Synthesis Market : Top-Down and Bottom-Up Approach
Data Triangulation
After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and obtain the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Peptide synthesis is the process of producing peptides through the controlled assembly of amino acids into specific sequences using chemical, biological, or hybrid manufacturing approaches.
The peptide synthesis market comprises the global commercial market for products and services used to chemically or biologically synthesize, modify, purify, and characterize peptides for research, drug discovery and development, diagnostics, therapeutics, and other life science applications. The market includes peptide synthesis instruments and systems, synthesis reagents and building blocks, purification and analytical instruments, synthesis-related consumables, and custom peptide synthesis services. Services covered include custom peptide synthesis, peptide engineering and modification, peptide labeling and conjugation, peptide purification, and peptide-specific analytical and characterization services provided by CROs, CDMOs and specialized peptide service providers.
Key Stakeholders
- Peptide synthesis instrument manufacturers
- Peptide synthesis reagent and consumable suppliers
- Custom peptide synthesis and specialized peptide service providers
- Pharmaceutical & biotechnology companies
- Contract research organizations (CROs) & contract development and manufacturing organizations (CDMOs)
- Academic & research institutes
- Medical device companies
- Clinical & diagnostic laboratories
- Market research & consulting firms
- Regulatory bodies
Report Objectives
- To define, describe, and forecast the global peptide synthesis market based on offering, product type, technique, service type, application, product end user, service end user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall peptide synthesis market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa
- To strategically profile the key players and comprehensively analyze their product & service portfolios, market positions, and core competencies
- To track and analyze competitive developments such as acquisitions, product & service launches, expansions, and R&D activities in the peptide synthesis market
- To analyze and provide funding & investment activities, brand/product/service comparative analysis, and vendor valuation & financial metrics of the peptide synthesis market
Available customizations:
Based on the given market data, MarketsandMarkets offers customization to meet the company’s specific needs. The following customization options are available for this report:
Portfolio Assessment
- Product Matrix, which gives a detailed comparison of the product portfolios of the top four companies.
Company Information
-
Detailed analysis and profiling of additional market players (up to five).
Geographical Analysis
- A further breakdown of the Rest of Europe peptide synthesis market, by country
- A further breakdown of the Rest of Asia Pacific peptide synthesis market, by country
- A further breakdown of the Rest of Latin America peptide synthesis market, by country
Get the Full Peptide Synthesis Market Report
Full forecast, segment splits, and company analysis for all Peptide Synthesis Market.
- Canada Peptide Synthesis Market
- US Peptide Synthesis Market
- Germany Peptide Synthesis Market
- UK Peptide Synthesis Market
- France Peptide Synthesis Market
- Italy Peptide Synthesis Market
- Spain Peptide Synthesis Market
- China Peptide Synthesis Market
- Japan Peptide Synthesis Market
- India Peptide Synthesis Market
- South Korea Peptide Synthesis Market
- Australia Peptide Synthesis Market
- Brazil Peptide Synthesis Market
- Mexico Peptide Synthesis Market
- Saudi Arabia Peptide Synthesis Market
- UAE Peptide Synthesis Market
- Rest Of Europe Peptide Synthesis Market
- Rest Of Asia Pacific Peptide Synthesis Market
- Rest Of Latin America Peptide Synthesis Market
- Rest Of GCC Countries Peptide Synthesis Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
